About: Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 08 May 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2007 (uk) im Mai 2007 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 2007 (ast) scientific article published on 08 May 2007 (en)
publication date	wds:Q80374875-FD21F050-3F92-46E1-8499-FDD2E711A1E6
publication date	2007-05-08 00:00:00Z (xsd:dateTime)
cites work	wds:Q80374875-0B1EDE55-D105-4A10-BE43-CC4938119BDA wds:Q80374875-1343FCE0-7622-4A1C-8256-FA3EA25D043B wds:Q80374875-1D86F07E-FCCA-41C0-916E-7FC99DF1B3F2 wds:Q80374875-3B0FA6C1-E13B-4E7A-B6AB-EA6E6352BD8E wds:Q80374875-84695EBA-81F1-4E2C-B768-5AD0006802ED
cites work	Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study Use of the case-control approach in vaccine evaluation: efficacy and adverse effects Genetic variation of Japanese encephalitis virus in nature Exact inference for matched case-control studies. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study
author name string	wds:Q80374875-3F6F1BC0-0385-43E7-BAC2-C7279F7327C8 wds:Q80374875-5961B797-7FB1-4E22-BAD0-6D4B6128C931 wds:Q80374875-5E94542A-57E6-4A6A-BF93-9D435E6F2EF3 wds:Q80374875-65B2AF2F-C96E-4548-939C-4EA944E5F684 wds:Q80374875-94A90A26-4B56-4893-AFF4-9708856D8DA8 wds:Q80374875-DD9919A2-1B55-4730-A505-539859F2C8A9
author name string	Scott B Halstead Min Ji Heechoul Ohrr Young Mo Sohn Sutee Yoksan J B Tandan
rdfs:label	Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com (en) Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com (nl)
skos:prefLabel	Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com (en) Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com (nl)
name	Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com (en) Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com (nl)
author	wds:Q80374875-47534DE7-3A8D-4AA5-9FFA-C29A84C8AF9F
author	Chung Mo Nam
title	wds:Q80374875-766C5194-8216-4725-B15D-9B77BA22D5ED
title	Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com (en)
page(s)	wds:Q80374875-1E78E0E9-9719-45D5-9C48-2E4071D8E30E
page(s)	5041-5045
instance of	wds:Q80374875-FB759C67-7DAC-4C05-9F5E-67AD73E8DFD4
instance of	scholarly article
main subject	wds:Q80374875-27544FC2-9945-4C23-8037-A7C17DCD3963 wds:Q80374875-2E4F5E5E-A362-44DE-9BBF-E1958AD55962 wds:Q80374875-B5C7A256-4429-4046-9C9E-A6EFD2B6BE20
main subject	encephalitis Japanese encephalitis vaccine
PubMed ID	wds:Q80374875-638C1A51-A9DA-4BF1-A74D-3E72D6EC60B2
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17521781
PubMed ID	17521781
published in	wds:Q80374875-7D4D85C1-3BE4-4961-AE43-05E1F73DF95C
published in	Vaccine
issue	wds:Q80374875-CA8BC538-A92C-446C-B13D-8826308074C6
volume	wds:Q80374875-1B3D0F03-C0E3-408D-9332-E0881F22BA7F
issue	27
volume	25
DOI	wds:Q80374875-0A08C222-4F5C-4A91-A07F-B7FAF008C459
DOI	http://dx.doi.org/10.1016/J.VACCINE.2007.04.052
DOI	10.1016/J.VACCINE.2007.04.052
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80374875
is cites work of	Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2. Genetic and phenotypic properties of vero cell-adapted Japanese encephalitis virus SA14-14-2 vaccine strain variants and a recombinant clone, which demonstrates attenuation and immunogenicity in mice Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2. Recombinant chimeric Japanese encephalitis virus/tick-borne encephalitis virus is attenuated and protective in mice A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities Formalin Inactivation of Japanese Encephalitis Virus Vaccine Alters the Antigenicity and Immunogenicity of a Neutralization Epitope in Envelope Protein Domain III. Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia Japanese encephalitis: the virus and vaccines A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults Encephalitis temporally associated with live attenuated Japanese encephalitis vaccine: four case reports The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children. Estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants Lot-to-lot consistency of live attenuated SA 14-14-2 Japanese encephalitis vaccine manufactured in a good manufacturing practice facility and non-inferiority with respect to an earlier product The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance. Past, present, and future of Japanese encephalitis Promise of new Japanese encephalitis vaccines Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51 A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses Dengue virus and Japanese encephalitis virus epidemiological shifts in Nepal: a case of opposing trends New vaccines for Japanese encephalitis A novel low-cost approach to estimate the incidence of Japanese encephalitis in the catchment area of three hospitals in Bangladesh Immunogenicity and safety of currently available Japanese encephalitis vaccines: a systematic review Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine: randomized, double-blind, 5-year phase II study in healthy adults Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis. Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity Humanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In Vivo Infection of mouse bone marrow-derived dendritic cells by live attenuated Japanese encephalitis virus induces cells maturation and triggers T cells activation Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 179 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software